flecainide has been researched along with Chronic Illness in 26 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We tested the hypothesis that the response to flecainide infusion can identify patients with atrial fibrillation (AF) in whom the hybrid pharmacologic and ablation therapy reduces the recurrences of AF." | 9.09 | Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation. ( Astarita, C; De Matteis, C; De Simone, A; Di Napoli, T; La Rocca, V; Maresca, F; Nocerino, P; Stabile, E; Stabile, G; Turco, P; Vitale, DF, 2001) |
| "The efficacy and safety of flecainide were studied in the maintenance of sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter." | 9.06 | Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. ( Crijns, HJ; Hamer, HP; Lie, KI; Van Gelder, IC; Van Gilst, WH; Van Wijk, LM, 1989) |
| " flecainide has a high efficacy for the treatment of experimentally-induced acute atrial fibrillation (AF) in horses and that its use is associated with minimal toxic side effects." | 7.72 | Use of intravenous flecainide in horses with naturally-occurring atrial fibrillation. ( Blissitt, KJ; Keen, JA; van Loon, G; Young, LE, 2004) |
| "Chronic persistent atrial fibrillation was converted in 13/19 (68%) patients at baseline and in 16/19 (84%) patients after flecainide." | 7.70 | Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation. ( Ayers, GM; Biffi, M; Boriani, G; Branzi, A; Bronzetti, G; Capucci, A; Magnani, B; Zannoli, R, 1999) |
| "During a one-week short-term in-hospital period, 60 patients with chronic ventricular arrhythmias were treated with 200 mg flecainide twice a day." | 7.67 | Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias. ( Balakumaran, K; Hagemeijer, F; Hugenholtz, PG; Jovanovic, A; Lubsen, J; Polak, BC; Roelandt, J; ten Cate, FJ; Vanhaleweyk, G; Withagen, A, 1984) |
| "The efficacy and safety of oral flecainide for treatment of ventricular arrhythmias were assessed during a 3-day period in patients with various cardiac diseases." | 7.67 | Oral flecainide for suppression of ventricular arrhythmias. ( Balakumaran, K; Hugenholtz, PG; Lubsen, J; Roelandt, J; Vanhaleweyk, G, 1984) |
| "The long-term efficacy and safety of flecainide (100 to 200 mg twice a day) were evaluated in 21 patients with high-grade, chronic ventricular arrhythmias who responded to and tolerated flecainide at a preliminary evaluation (200 mg, single oral dose)." | 7.67 | Efficacy and safety of flecainide in low-risk patients with chronic ventricular arrhythmias: a two-year follow-up. ( Bonazzi, O; Facchini, M; Priori, SG; Schwartz, PJ; Songa, V; Varisco, T, 1989) |
| "The objective of this study was to evaluate the haemodynamic and antiarrhythmic effects of flecainide acetate in patients with heart failure." | 7.67 | Haemodynamic and antiarrhythmic effects of intravenous flecainide acetate in chronic congestive heart failure. ( Dijk, A; Dunselman, PH; Kingma, JH; Lie, KI; van Wijk, LM; Wesseling, H, 1985) |
| "The efficacy of the new class Ic anti-arrhythmic (aa) drug, Flecainide, has been evaluated in patients (pts) affected by frequent and/or severe chronic ventricular arrhythmias (VA), as assessed by 24 hours Holter monitoring and maximal exercise stress testing." | 7.67 | [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method]. ( Bonazzi, O; Cuspidi, C; Facchini, M; Priori, S; Schwartz, PJ; Varisco, T; Zuanetti, G, 1985) |
| "After an initial pilot study in five patients, the effect of flecainide on chronic ventricular arrhythmias was tested during 48-hour oral administration of 250 mg twice a day in nine further patients with previously drug-resistant chronic, stable ventricular arrhythmias." | 7.66 | [Effect of flecainide on chronic ventricular arrhythmias (author's transl)]. ( Abendroth, RR; Bluschke, V; Breithardt, G; Seipel, L, 1982) |
| "We tested the hypothesis that the response to flecainide infusion can identify patients with atrial fibrillation (AF) in whom the hybrid pharmacologic and ablation therapy reduces the recurrences of AF." | 5.09 | Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation. ( Astarita, C; De Matteis, C; De Simone, A; Di Napoli, T; La Rocca, V; Maresca, F; Nocerino, P; Stabile, E; Stabile, G; Turco, P; Vitale, DF, 2001) |
| "The efficacy and safety of flecainide were studied in the maintenance of sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter." | 5.06 | Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. ( Crijns, HJ; Hamer, HP; Lie, KI; Van Gelder, IC; Van Gilst, WH; Van Wijk, LM, 1989) |
| " flecainide has a high efficacy for the treatment of experimentally-induced acute atrial fibrillation (AF) in horses and that its use is associated with minimal toxic side effects." | 3.72 | Use of intravenous flecainide in horses with naturally-occurring atrial fibrillation. ( Blissitt, KJ; Keen, JA; van Loon, G; Young, LE, 2004) |
| "Chronic persistent atrial fibrillation was converted in 13/19 (68%) patients at baseline and in 16/19 (84%) patients after flecainide." | 3.70 | Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation. ( Ayers, GM; Biffi, M; Boriani, G; Branzi, A; Bronzetti, G; Capucci, A; Magnani, B; Zannoli, R, 1999) |
| "During a one-week short-term in-hospital period, 60 patients with chronic ventricular arrhythmias were treated with 200 mg flecainide twice a day." | 3.67 | Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias. ( Balakumaran, K; Hagemeijer, F; Hugenholtz, PG; Jovanovic, A; Lubsen, J; Polak, BC; Roelandt, J; ten Cate, FJ; Vanhaleweyk, G; Withagen, A, 1984) |
| "The efficacy and safety of oral flecainide for treatment of ventricular arrhythmias were assessed during a 3-day period in patients with various cardiac diseases." | 3.67 | Oral flecainide for suppression of ventricular arrhythmias. ( Balakumaran, K; Hugenholtz, PG; Lubsen, J; Roelandt, J; Vanhaleweyk, G, 1984) |
| "The long-term efficacy and safety of flecainide (100 to 200 mg twice a day) were evaluated in 21 patients with high-grade, chronic ventricular arrhythmias who responded to and tolerated flecainide at a preliminary evaluation (200 mg, single oral dose)." | 3.67 | Efficacy and safety of flecainide in low-risk patients with chronic ventricular arrhythmias: a two-year follow-up. ( Bonazzi, O; Facchini, M; Priori, SG; Schwartz, PJ; Songa, V; Varisco, T, 1989) |
| " Both the intravenous efficacy and the oral efficacy of 2 class IC antiarrhythmic drugs, encainide and flecainide, were studied in 16 patients with atrial ectopic tachycardia and in 3 patients with junctional ectopic tachycardia, using exercise testing, 24-hour long-term electrocardiography and programmed electrical stimulation." | 3.67 | Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia. ( Duckeck, W; Kuck, KH; Kunze, KP; Schlüter, M, 1988) |
| "The objective of this study was to evaluate the haemodynamic and antiarrhythmic effects of flecainide acetate in patients with heart failure." | 3.67 | Haemodynamic and antiarrhythmic effects of intravenous flecainide acetate in chronic congestive heart failure. ( Dijk, A; Dunselman, PH; Kingma, JH; Lie, KI; van Wijk, LM; Wesseling, H, 1985) |
| "The efficacy of the new class Ic anti-arrhythmic (aa) drug, Flecainide, has been evaluated in patients (pts) affected by frequent and/or severe chronic ventricular arrhythmias (VA), as assessed by 24 hours Holter monitoring and maximal exercise stress testing." | 3.67 | [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method]. ( Bonazzi, O; Cuspidi, C; Facchini, M; Priori, S; Schwartz, PJ; Varisco, T; Zuanetti, G, 1985) |
| "After an initial pilot study in five patients, the effect of flecainide on chronic ventricular arrhythmias was tested during 48-hour oral administration of 250 mg twice a day in nine further patients with previously drug-resistant chronic, stable ventricular arrhythmias." | 3.66 | [Effect of flecainide on chronic ventricular arrhythmias (author's transl)]. ( Abendroth, RR; Bluschke, V; Breithardt, G; Seipel, L, 1982) |
| "Left bundle branch block was induced in 12 canines." | 1.40 | Electrophysiological and haemodynamic effects of vernakalant and flecainide in dyssynchronous canine hearts. ( Auricchio, A; Houthuizen, P; Kuiper, M; Maessen, JG; Prinzen, FW; Strik, M; van Middendorp, LB, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (50.00) | 18.7374 |
| 1990's | 7 (26.92) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 2 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ermakov, S | 1 |
| Hoffmayer, KS | 1 |
| Gerstenfeld, EP | 1 |
| Scheinman, MM | 1 |
| van Middendorp, LB | 1 |
| Strik, M | 1 |
| Houthuizen, P | 1 |
| Kuiper, M | 1 |
| Maessen, JG | 1 |
| Auricchio, A | 1 |
| Prinzen, FW | 1 |
| van Loon, G | 1 |
| Blissitt, KJ | 1 |
| Keen, JA | 1 |
| Young, LE | 1 |
| Narayan, G | 1 |
| Akhtar, M | 1 |
| Sra, J | 1 |
| Birettoni, F | 1 |
| Porciello, F | 1 |
| Rishniw, M | 1 |
| della Rocca, G | 1 |
| Di Salvo, A | 1 |
| Sgorbini, M | 1 |
| Bluschke, V | 1 |
| Breithardt, G | 1 |
| Abendroth, RR | 1 |
| Seipel, L | 1 |
| Vanhaleweyk, G | 2 |
| Balakumaran, K | 2 |
| Lubsen, J | 2 |
| ten Cate, FJ | 1 |
| Jovanovic, A | 1 |
| Hagemeijer, F | 1 |
| Withagen, A | 1 |
| Polak, BC | 1 |
| Roelandt, J | 2 |
| Hugenholtz, PG | 2 |
| Zarembski, DG | 1 |
| Nolan, PE | 1 |
| Slack, MK | 1 |
| Caruso, AC | 1 |
| Mannino, MM | 1 |
| Mehta, D | 1 |
| Gomes, JA | 1 |
| Leclercq, JF | 1 |
| Bizot, J | 1 |
| Attuel, P | 1 |
| Coumel, P | 1 |
| Boriani, G | 1 |
| Biffi, M | 1 |
| Capucci, A | 1 |
| Bronzetti, G | 1 |
| Ayers, GM | 1 |
| Zannoli, R | 1 |
| Branzi, A | 1 |
| Magnani, B | 1 |
| Wijffels, MC | 1 |
| Dorland, R | 1 |
| Allessie, MA | 1 |
| Stabile, G | 1 |
| De Simone, A | 1 |
| Turco, P | 1 |
| La Rocca, V | 1 |
| Nocerino, P | 1 |
| Astarita, C | 1 |
| Maresca, F | 1 |
| De Matteis, C | 1 |
| Di Napoli, T | 1 |
| Stabile, E | 1 |
| Vitale, DF | 1 |
| Guarnieri, T | 1 |
| Tomaselli, G | 1 |
| Griffith, LS | 1 |
| Brinker, J | 1 |
| Crijns, HJ | 2 |
| Van Gelder, IC | 2 |
| Van Gilst, WH | 2 |
| Hillege, H | 1 |
| Gosselink, AM | 1 |
| Lie, KI | 3 |
| Mangini, SG | 1 |
| Mastropasqua, F | 1 |
| Lagioia, R | 1 |
| Ricci, A | 1 |
| Scrutinio, D | 1 |
| Rizzon, P | 1 |
| Gladman, G | 1 |
| Wilkinson, JL | 1 |
| Evans-Jones, G | 1 |
| Facchini, M | 3 |
| Varisco, T | 3 |
| Bonazzi, O | 3 |
| Priori, SG | 2 |
| Songa, V | 1 |
| Schwartz, PJ | 3 |
| Van Wijk, LM | 2 |
| Hamer, HP | 1 |
| Kunze, KP | 2 |
| Kuck, KH | 2 |
| Schlüter, M | 2 |
| Bleifeld, W | 1 |
| Duckeck, W | 1 |
| Dunselman, PH | 1 |
| Kingma, JH | 1 |
| Dijk, A | 1 |
| Wesseling, H | 1 |
| Cuspidi, C | 1 |
| Priori, S | 1 |
| Zuanetti, G | 1 |
| Raviele, A | 1 |
| Piccolo, E | 1 |
1 review available for flecainide and Chronic Illness
| Article | Year |
|---|---|
Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; | 1995 |
3 trials available for flecainide and Chronic Illness
| Article | Year |
|---|---|
Treatment of chronic atrial fibrillation in the horse with flecainide: personal observation.
Topics: Animals; Anti-Arrhythmia Agents; Area Under Curve; Atrial Fibrillation; Chronic Disease; Flecainide; | 2007 |
Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation.
Topics: Administration, Oral; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Atria | 2001 |
Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutte | 1989 |
22 other studies available for flecainide and Chronic Illness
| Article | Year |
|---|---|
Combination drug therapy for patients with intractable ventricular tachycardia associated with right ventricular cardiomyopathy.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Chronic Disease; Dr | 2014 |
Electrophysiological and haemodynamic effects of vernakalant and flecainide in dyssynchronous canine hearts.
Topics: Action Potentials; Animals; Anisoles; Anti-Arrhythmia Agents; Blood Pressure; Bundle-Branch Block; C | 2014 |
Use of intravenous flecainide in horses with naturally-occurring atrial fibrillation.
Topics: Acute Disease; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Chronic D | 2004 |
Combined use of 1C and III agents for highly symptomatic, refractory atrial fibrillation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Drug Combinations; Female | 2006 |
[Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
Topics: Adult; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Arrhythmias, Cardiac; Cardiac Complexes, Prema | 1982 |
Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Dizziness; Drug Evaluation; Electrocardiography; | 1984 |
Oral flecainide for suppression of ventricular arrhythmias.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Dr | 1984 |
Current treatment options for paroxysmal supraventricular tachycardia.
Topics: Acute Disease; Catheter Ablation; Chronic Disease; Flecainide; Humans; Propafenone; Tachycardia, Atr | 1994 |
Direct-current cardioversion of atrial tachyarrhythmias under oral flecainide therapy.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Chronic Disease; Electric Countershock; Electroc | 1997 |
Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Catheterization; Chronic Disease; | 1999 |
Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Disease Models, Animal; Elect | 1999 |
The interaction of antiarrhythmic drugs and the energy for cardioversion of chronic atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cerebrovascular Disorders; Chr | 1991 |
Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.
Topics: Actuarial Analysis; Aged; Amiodarone; Analysis of Variance; Atrial Fibrillation; Atrial Flutter; Chr | 1991 |
[Non-invasive evaluation of the effectiveness of flecainide in the treatment of ventricular extrasystole arrhythmia].
Topics: Adult; Aged; Cardiac Complexes, Premature; Chronic Disease; Female; Flecainide; Heart Ventricles; Hu | 1986 |
Pseudocardiomyopathy secondary to chronic incessant supraventricular tachycardia.
Topics: Cardiomyopathy, Dilated; Child; Chronic Disease; Flecainide; Humans; Male; Tachycardia, Supraventric | 1989 |
Efficacy and safety of flecainide in low-risk patients with chronic ventricular arrhythmias: a two-year follow-up.
Topics: Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Electrocardiography; Exercise Test; Female; Flec | 1989 |
Effect of encainide and flecainide on chronic ectopic atrial tachycardia.
Topics: Adult; Anilides; Chronic Disease; Electrophysiology; Encainide; Female; Flecainide; Heart Atria; Hum | 1986 |
Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Di | 1987 |
Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anilides; Anti-Arrhythmia Agents; Chronic Disease; El | 1988 |
Haemodynamic and antiarrhythmic effects of intravenous flecainide acetate in chronic congestive heart failure.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Electrocardiography; Flecainide; Hear | 1985 |
[Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Female; Flecainide; Heart | 1985 |
[Flecainide in the treatment of chronic ventricular arrhythmia].
Topics: Arrhythmias, Cardiac; Chronic Disease; Flecainide; Heart Ventricles; Humans; Piperidines | 1985 |